Studies a device treatment for uncontrolled high blood pressure in older adults
Tests a kidney nerve-targeting ultrasound device in adults with uncontrolled high blood pressure.
Plain-language title generated from the registry record
Registry title: The RADIANCE CED Study
Key facts
- Where
- Detroit, United StatesSee the 2 sites
Where in United States
- Henry Ford HospitalDetroit, United StatesTaking people
- Henry Ford St. John HospitalDetroit, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- ReCor Medical, Inc.
- Trial code
- NCT07231757
- Record updated
- 16 July 2026
- Original description
The RADIANCE CED study is a prospective observational study designed to evaluate the long-term effectiveness of ultrasound renal denervation in lowering blood pressure among patients with uncontrolled hypertension. Data will be collected from electronic health records (EHRs) of Medicare-eligible patients to support generalizability of outcomes to the broader Medicare population. Individual hospital enrollment is not required for this study and IRB exemption has been received by sponsor.Read full original descriptionShow less
The Recor Paradise System™ Hypertension Coverage With Evidence Development Study
The RADIANCE CED study is a prospective observational study designed to evaluate the long-term effectiveness of ultrasound renal denervation in lowering blood pressure among patients with uncontrolled hypertension. Data will be collected from electronic health records (EHRs) of Medicare-eligible patients to support generalizability of outcomes to the broader Medicare population. Individual hospital enrollment is not required for this study and IRB exemption has been received by sponsor.
Common Inclusion Criteria:; Adults aged ≥65 years with uncontrolled hypertension; Stable regimen of blood pressure-lowering medication; Common Exclusion Criteria:; Hypertension due to secondary causes; Prior renal denervation treatment; Pregnancy; End-stage renal disease, dialysis, or kidney transplant.